Insulin Delivery Devices Market Size, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

Insulin Delivery Devices Market Size and Growth 2026 to 2035

The global insulin delivery devices market size is valued at USD 21.13 billion in 2025 and is predicted to increase from USD 22.50 billion in 2026 to approximately USD 39.12 billion by 2035, expanding at a CAGR of 6.35% from 2026 to 2035.

Key Takeaways

• North America led the global market with the highest market share of 31% in 2025.
• By product, the insulin pen segment has held the largest market share of 38% in 2025.
• By end user, the home care segment captured the biggest revenue share of 50% in 2025.
• By distribution channel, the incident delivery devices segment registered the maximum market share in 2025.

What are Insulin Delivery Devices?

The continuing rapid growth of the global insulin delivery devices market is attributed to the increasing number of people diagnosed with diabetes globally, greater education surrounding early intervention in disease progression, and continual technological advancements that are being developed rapidly. The development of insulin pen devices, pumps, or continuous subcutaneous insulin infusion (CSII), as well as smart insulin delivery system technology, is significantly improving patient convenience and therefore enhancing the rate at which patients adhere to their insulin therapy regimen.

The increasing demand for efficient, easy-to-use devices that provide accurate and reliable delivery of insulin via a minimally invasive method in the patient's home has led to the acceleration of the growth of this emerging market segment, which is becoming an integral part of modern-day diabetes management.

There are many ways in order to administer insulin to a patient. It is a hormone that helps in regulating the blood sugar levels of the diabetic patients. This hormone can be administered by the way of pens, pumps, jet sprays and syringes. The growing prevalence of diabetes is an important factor for the growth of the market. It also happens to be a major reason for surging mortality rate. It's about 1.5 million deaths due to diabetes in 2019 according to the report of the World Health Organization. The diabetic patients use the available insulin delivery devices in order to access the insulin dose which helps in regulating the hormone by maintaining the blood sugar of the patient. Administering insulin in the form of up tablet is also not possible as it gets degenerated by the digestive enzymes. Therefore there are a wide range of devices that are used in order to deliver the insulin at the correct location.

During the pandemic the patients with comorbidity contracted the disease earlier. About 40% of the hospitals has diabetic patients suffering with COVID-19. There were disruptions in the supply chain, shipping delays and shut down of various manufacturing units.

AI in the Insulin Delivery Devices Market

The advancement of insulin delivery devices has been notable, with artificial intelligence playing a pivotal role in enhancing their precision and adaptability. AI algorithms, especially those utilizing reinforcement learning techniques, facilitate personalized insulin dosing by continuously adjusting to individual responses. A new clinical trial at the University of Virginia aims to streamline diabetes management by evaluating an AI-powered device designed to enhance automated insulin delivery.

Insulin Delivery Devices Market Growth Factors

The increasing prevalence of diabetes which is mainly due to obesity, aging or unhealthy lifestyle is expected to help in the growth of the market. Obesity happens to be the major factor causing diabetes. The number of diabetic patients across the world is increasing mainly in the obese or overweight patients. The diabetes off lifted population in the nations is driving the market for the insulin delivery devices. There's an increased demand for these devices due to various innovations. As an increasing expenditure on diabetes care the market for the insulin delivery devices is expected to grow. Due to the favorable reimbursement policies another option of other facilitative initiatives are helping in the growth of the market. The progressive and the chronic nature of diabetes inflicts the use of insulin over a long period of time. The pandemic has also proven to be a great factor in the expansion of insulin delivery devices market. As the population afflicted with diabetes across the globe is increasing it is driving the market for the Insulin delivery devices.

Insulin Delivery Devices Market Outlook

• Industry Growth Overview: The growth of the industry has been fueled by an increased incidence of diabetes, technological advancements, and an increased preference for using self-administered devices to administer insulin. The emergence and continuing improvement of smart connected insulin delivery systems will play a significant role in future growth opportunities.
• Sustainability Trends: Companies that manufacture insulin delivery devices have begun to focus on using sustainable materials, creating reusable insulin delivery pens, and reducing their plastic footprint. Products that use sustainable packaging and extend the lifespan of the devices are expected to be valued by consumers more than those that do not.
• Global Expansion: The emerging economies will be a focus for the continued growth of the insulin delivery device industry as manufacturers expand their manufacturing, distribution, and pricing strategies to take advantage of the growing populations of people with diabetes not being served.
• Startup Ecosystem: Startups are driving innovative ideas in the area of insulin delivery devices with the introduction of artificial intelligence-powered insulin pumps, digital tracking of doses, and designs that are focused on the needs of patients. Collaborations between established companies and startups are accelerating the commercialization and entry into the marketplace of new insulin delivery devices.

Market Scope

Segments Insights

Type Insights

Why did Insulin Pens Segment Dominate the Insulin Delivery Devices Market in 2025?

The insulin pens segment dominated the market in 2025. The growing preference for insulin pens is due to the various benefits that it offers. These insulin pens are available at an affordable cost and they are technologically advanced among all the other devices. Many people across the world prefer insulin pens as it is easy to use and also limit the financial burden of the patient, as it is pocket friendly. In the future, the development of smart pens is also expected to drive the market for insulin pens.

The insulin pumps segment is expected to grow at the fastest rate during the forecast period. This is driven by convenience and precise methods of managing their blood glucose levels. Growing diabetes prevalence and rising technology acceptance are increasing demand for insulin pumps. The companies are developing advanced insulin pumps with sophisticated technology.

By Application

How did the Type II Diabetes Segment Dominate the Insulin Delivery Devices Market in 2025?

Type II diabetes segment held the largest share of the market in 2025. This is due to the rising prevalence of type II diabetes because of factors such as the obesity epidemic, a lifestyle that lacks physical exercise, and aging. Long-term insulin therapy is common among patients with type 2 diabetes who need convenient delivery methods like insulin pens and pumps.

Type I diabetes segment is expected to grow at the fastest rate during the forecast period. Prevalence of type I diabetes is rising due to growing adoption of Western diets, sedentary lifestyles, and rising awareness of Type 1 diabetes risks, driving demand for insulin delivery devices. Type 1 diabetes patients also use devices like insulin syringes, pens, and pumps to administer a steady amount of insulin to the body.

Product Insights

Why is the insulin pen segment expected to hold the highest market share during the forecast period?

The insulin pen segment accounted for the largest market share 38% in 2023. The insulin pens segment shall have the highest market share as there's an increasing preference due to the various benefits that it offers. These insulin pens are available at affordable cost and they are technologically advanced among all the other devices. Many people across the globe prefer insulin pen as it is easy to use and it also limits the financial burden of the patient as it is pocket friendly.

In the future the development of smart pen is also expected to drive the market of the insulin pen. The increasing number of diabetic patients are using insulin pen due to the convenience in usage. Other products like the insulin pump or the hand syringes are also used to administer insulin. All of these delivery devices also share a good market growth during the forecast.

End User Insights

Which End User Segment Dominated the Market in 2025?

The home care segment dominated the market and is anticipated to grow at the fastest rate during the forecast period. This is due to insulin delivery devices offering patients the convenience of managing their diabetes at home. As diabetes is a chronic disease that keeps on rising with every passing year, it poses a great healthcare expenditure. The growing pressure to reduce these expenses helps in adopting the devices that are easy to use in home care settings.

Significant advancements in these devices and the availability helps in driving the market beaded does a higher option rate of the smart insulin pen in the home care settings. It has a supporting smartphone application and a reusable injector pen which is extremely efficient in managing the delivery of insulin. As there is an increased awareness amongst the patient regarding the insulin delivery devices for home use the market shall grow during the forecast period.

Distribution Channel Insights

Which Distribution Channel Segment Dominated the Market In 2025?

The retail pharmacies segment held the largest share of the market in 2025. This is due to their accessibility, convenience, and personalized support. Patients choose retail pharmacies for immediate access to insulin and supplies, along with guidance from pharmacists who can guide with usage and address concerns. These pharmacies have developed infrastructure for dispensing devices and managing insurance claims, simplifying the process for patients. This preference is further supported by the widespread availability of retail pharmacies within local communities.

The online sales segment is anticipated to grow with the highest CAGR during the forecast period. This is due to its convenience, cost-effectiveness, and growing adoption during and after the pandemic. Online pharmacies offer price comparisons, doorstep delivery, and discounts, making them a popular choice for consumers. They also enable users to compare prices from various retailers, potentially leading to significant savings, especially with generic or private-label brands.

Regional Insights

North American Region has Dominated the Market of Insulin Delivery Devices

The North American region has dominated the market of insulin delivery devices in 2025 and has garnered a market share of 30.14%. An increasing diabetic population and availability of technologically advanced devices across the North American region is helping in the growth of the market. The increasing patient base of diabetes is expected to boost the growth of the market in this region.

U.S. Insulin Delivery Devices Market Size and Growth 2026 to 2035

The U.S. insulin delivery devices market size is estimated at USD 4.59 billion in 2025 and is predicted to be worth around USD 8.56 billion by 2035, at a CAGR of 6.43% from 2026 to 2035.

U.S. Market Trends

The U.S. market is growing due to the rising prevalence of diabetes across the nation, increased healthcare spending on diabetes management, and rapid technological advancements in insulin delivery systems. In March 2026, Sequel Med Tech announced the broad availability of its TWIIST automated insulin delivery system in the U.S., with plans to expand access for individuals with type 1 diabetes.

Why is the Market in Asia Pacific Growing at the Fastest Rate?

The market for insulin delivery devices in the Asia Pacific region is also expected to grow fast during the forecast period. In many developing economies like India and China there shall be the highest growth other than increasing population based suffering from diabetes and the awareness about the treatments for the same. Another major factor contributing to the growth in the Asia Pacific region is the high end products that are available in the market in order to treat diabetes.

China Market Trends

China has the largest number of individuals who need insulin regularly. This has increased the demand for more advanced methods of delivering the drug. Rising use of insulin pens and patch pumps, along with greater insurer reimbursement support, is driving rapid market growth in China. Additionally, domestic companies are forming partnerships with global firms to improve access to minimally invasive delivery devices, thereby contributing to market expansion.

What Drives the European Insulin Delivery Devices Market?

The market in Europe is driven by a well-structured national health system and the increasing adoption of wearable technologies. The growth of wearables, particularly those designed to monitor glucose levels and deliver insulin, is contributing to a rise in the number of individuals using diabetes care technologies. A growing awareness of diabetes management across various age groups also drives market growth.

Europe Injects Innovation: Notable Growth in the Insulin Delivery Devices Industry

Europe has an established market for insulin delivery devices; however, Europe's innovative development path continues to be fueled by the region's established reimbursement systems and high level of development in healthcare technology.

Countries such as Germany, France, and the U.K. continue to invest heavily in Insulin pumps and smart pens, while the region has a growing number of elderly persons and a growing number of persons diagnosed with diabetes. Europe is set to take the lead in the integration of digital health technologies, with connected insulin delivery devices, data-driven monitoring platforms, and long-term sustainable disease management.

Germany Market Trends

Germany boasts a robust healthcare infrastructure, which has rapidly advanced with the integration of cutting-edge technologies in insulin delivery. The country is investing significantly in research and development in the diabetes care sector, with the government offering financial incentives to companies developing digital solutions to improve treatment management. This commitment to innovation is accelerating the development of advanced diabetes care technologies, making it easier for individuals to manage their condition effectively.

Latin America's Diabetes Care Leap: Notable Growth in the Insulin Delivery Devices Industry

With an increasing number of users worldwide, Latin America is a developing region for insulin delivery devices due to a growing population suffering from diabetes, the urbanization of lifestyle habits, and enhanced access to healthcare. As Brazil, Mexico, and Argentina are investing in raising awareness about diabetes and creating better public health systems for controlling and managing the disease, there has been an increase in the ability of users to afford the use of insulin pens and other reusable devices.

The ability for users to get access to advanced methods of delivering insulin has also been aided by the expansion of international manufacturers' distribution networks, enabling them to provide their products at a wider range of locations throughout Latin America.

Brazil Market Trends

In Brazil, the market for insulin delivery devices is driven by the increasing prevalence of diabetes, attributed to urbanization, sedentary lifestyles, and dietary changes. Government programs, such as the Sistema Único de Saúde, provide free or subsidized access to insulin, further supporting patient care. The focus on patient-centric solutions and improved quality of life is also propelling demand for smart insulin delivery systems.

How is the Opportunistic Rise of the Middle East & Africa in the Insulin Delivery Devices Market?

The Middle East & Africa (MEA) is experiencing significant growth in the market due to the rising number of people with diabetes, greater access to insulin devices, and greater investment in modernizing healthcare systems. Additionally, government initiatives and improved access to healthcare services are facilitating greater availability and affordability of these devices, driving market growth across the region. The UAE leads the market in the region due to rising investments in healthcare infrastructure and growing rates of diabetes.

Saudi Arabia Market Trends

Saudi Arabia ranks among the top five countries in the Middle East and Africa region and the top ten worldwide for diabetes prevalence among adults, with an estimated age-standardized prevalence of 23.1%. Such growing prevalence of diabetes is driving the market. The increasing incidence of diabetes and related initiatives, such as the Ministry of Health (MOH) Vision for E-Health, are significant contributors to this trend.

Insulin Delivery Devices Market Value Chain Analysis

• R&D and Product Design: This stage involves the conceptualization of new devices, clinical validation, human factors studies, and the development of regulatory strategies to ensure that products are safe, effective, and user-friendly for the target patients.
• Component Sourcing and Precision Manufacturing: Key components such as cartridges, pumps, electronics, and sterile disposables are sourced, and precision manufacturing processes are applied to ensure quality, traceability, and compliance with regulatory standards before assembly.
• Device Assembly, Integration, and Testing: Devices are assembled in cleanroom environments, integrating all components, loading software, calibrating systems, and conducting thorough bench and clinical testing to ensure reliability and performance before commercial release.
• Regulatory Approvals, Packaging, and Distribution: This stage covers regulatory submissions, sterile and retail packaging, labelling, and cold-chain logistics to ensure that products meet all standards and reach hospitals, pharmacies, and patients safely and predictably.
• Post-Market Support: After commercial release, companies provide customer training, digital health support, product warranties, patient safety monitoring, service support, and programs for recycling and responsible disposal, ensuring ongoing product reliability and patient safety.
• Device Design & Manufacturing: At this stage, manufacturers are focused on R&D, engineering, and quality manufacturing of insulin delivery devices. Innovation, usability, and regulatory approval are three critical success factors at this stage.
  Distribution & Market Access: Manufacturers partner with distributors, hospitals, and pharmacies to facilitate an efficient channel for distributing their products into the market.
• End-User Adoption & Support: Healthcare providers (i.e., physicians), healthcare facilities (i.e., clinics), and home care consumers all contribute to driving demand for insulin delivery devices.

Insulin Delivery Devices Market Companies

• Novo Nordisk A/S
• Wockhardt Ltd.
• Medtronic
• F. Hoffmann-La Roche, Ltd.
• Abbott Laboratories
• Sanofi
• Eli Lilly and Company
• Biocon Ltd.
• Ypsomed AG
• Becton, Dickinson and Company

Recent Developments

• In June 2026, MiniMed announced the launch of two new insulin delivery systems featuring the Instinct sensor, specifically for the European market. The Northridge, California-based former Medtronic Diabetes division introduced the MiniMed 780G automated insulin delivery system, integrated with the Instinct sensor, along with the MiniMed Go system paired with the Instinct Go sensor.
• In May 2026, ViCentra, a European medical device company specializing in the Kaleido insulin patch pump system, announced the commercial launch of its innovative smartphone-controlled hybrid closed-loop system, with initial deliveries scheduled for Germany and the Netherlands later that summer.
• In March 2022, Novo Nordisk announced the launch of its smart insulin in the UK. This novel product launch will offer competitive advantage and strengthen its industrial position in the UK region.
• Medtronic launched the InPen smart insulin pen that is integrated with real-time Guardian Connect CGM data which offers real-time glucose readings coupled with insulin dose data and makes it easier to make smarter dosing decisions. This product launch assisted the company in driving the sales & revenue generation in insulin delivery devices market.

Segments Covered in Report

By Type

• Insulin Pumps
  • Tubed/Tethered
  • Tubeless
• Insulin Pens
  • Reusable
  • Disposable
• Insulin Pen needles
  • Standard
  • Safety
• Insulin Jet Injectors
• Insulin Syringes
• Others

By Application

• Type I Diabetes
• Type II Diabetes

By End User

• Home Care
• Hospitals & clinics
• Others

By Distribution Channels

• Online Sales
• Hospital Pharmacies
• Retail Pharmacies
• Other Clinics

By Region

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa